Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • DVN vs GSK✓SelectedUSD · GSKDVN vs GSK performance historyLatest closeAs of-3.45%11/18
Stock and ETF performance explorer

DVN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1.4%
GSK return
+56.0%
Excess return
-54.6%
Maximum drawdown
-49.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.5%-1.3%-2.1%-3.5%
7D-6.7%-3.1%-3.5%-6.7%
30D-17.6%-0.9%-16.7%-17.6%
3M-11.7%-4.2%-7.5%-11.6%
6M-14.4%-1.6%-12.8%-14.4%
YTD+16.7%+2.6%+14.1%+15.8%
1Y+20.0%+6.2%+13.7%+18.9%
All+1.4%+56.0%-54.6%-7.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling